XSHE
300082
Market cap782mUSD
Jul 10, Last price
7.78CNY
1D
-0.38%
1Q
-27.43%
Jan 2017
-7.93%
IPO
-73.31%
Name
Liaoning Oxiranchem Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Liaoning Oxiranchem, Inc. is a prominent Chinese enterprise whose core business revolves around the development, manufacturing, and distribution of sophisticated chemical products, specifically those derived from ethylene oxide. The company's product portfolio is diverse, featuring specialized solutions such as crystalline silicon cutting liquids essential for the photovoltaic industry, along with water-reducing agents vital for cement production. It also produces polyether monomers, ethylene carbonate, and polyethylene glycol (PEG). PEG, in particular, finds extensive utility across various sectors, including pharmaceuticals, personal care products, bio-based surfactants, advanced materials, and as specialized additives. Beyond these specific applications, Liaoning Oxiranchem's chemicals underpin a vast array of industries. They are integral to major infrastructure developments like high-speed rail networks, subway systems, airports, and expressways. Furthermore, their compounds are crucial in the formulation of cleaning agents, washing powders, pharmaceuticals, electronic components, automotive parts, textiles, printing inks, and dyes. Established in 2000, the company maintains its headquarters in Liaoyang, China, and operates as a subsidiary under the umbrella of Oxiranchem Holding Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||